ClinicalTrials.gov · NCT05297097 · Unknown status
The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers
Registry record
NCT05297097 on ClinicalTrials.gov. The registry's last update to this record was 8 September 2022.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor TruDiagnostic Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Trulacta breastmilk supplement Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Epigenetic Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Unknown status Checked Source clinicaltrials.gov Overall status as registered; registry last update 2022-09-08. Checked
Check history: NCT05297097 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: TruDiagnostic
- Phase: Phase 2
- Status: Unknown status
- Intervention: Trulacta breastmilk supplement
- Primary outcome: Epigenetic Age
- Countries: United States
- Start: 1 March 2022
- Completion (estimated): 30 December 2022
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.